A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation
- PMID: 36198881
- DOI: 10.1007/s00423-022-02687-2
A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation
Abstract
Purpose: A preoperative estimate of the risk of malignancy for intraductal papillary mucinous neoplasms (IPMN) is important. The present study carries out an external validation of the Shin score in a European multicenter cohort.
Methods: An observational multicenter European study from 2010 to 2015. All consecutive patients undergoing surgery for IPMN at 35 hospitals with histological-confirmed IPMN were included.
Results: A total of 567 patients were included. The score was significantly associated with the presence of malignancy (p < 0.001). In all, 64% of the patients with benign IPMN had a Shin score < 3 and 57% of those with a diagnosis of malignancy had a score ≥ 3. The relative risk (RR) with a Shin score of 3 was 1.37 (95% CI: 1.07-1.77), with a sensitivity of 57.1% and specificity of 64.4%.
Conclusion: Patients with a Shin score ≤ 1 should undergo surveillance, while patients with a score ≥ 4 should undergo surgery. Treatment of patients with Shin scores of 2 or 3 should be individualized because these scores cannot accurately predict malignancy of IPMNs. This score should not be the only criterion and should be applied in accordance with agreed clinical guidelines.
Keywords: Intraductal papillary mucinous neoplasm; Malignancy; Pancreatic neoplasm; Preoperative diagnosis; Score.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Roth S, Bose P, Alhamdani MSS, Mustafa SA, Tjaden C, Zamzow K et al (2020) Noninvasive discrimination of low and high-risk pancreatic intraductal papillary mucinous neoplasms. Ann Surg. https://doi.org/10.1097/SLA.0000000000004066 - DOI
-
- Attiyeh MA, Fernandez-Del Castillo C, Al Efishat MA, Eaton A, Gönen M, Batts R et al (2018) Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from the Pancreatic Surgery Consortium. Ann Surg 1:157–163 - DOI
-
- Tanaka M, Fernandez-Del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T et al (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17:738–753 - DOI
-
- Correa-Gallego C, Do R, Lafemina J, Gönen M, D’Angelica MI, DeMatteo RP et al (2013) Predicting dysplasia and invasivecarcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol 20:4348–4355 - DOI
-
- Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical